Moderna vaccine

(Reuters) – Moderna Inc’s experimental vaccine is 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far exceed expectations. Together with Pfizer Inc’s vaccine, which is also more than 90% effective, and pending more safety data and […]